REGN and NTLA Related Headlines

Oct 3, 2023 07:02AM Regeneron (REGN) and Intellia (NTLA) Announce Expanded Research Collaboration to Develop CRISPR-Based Therapies for the Treatment of Neurological and Muscular Diseases

Oct 3, 2023 07:00AM Regeneron and Intellia Announce Expanded Research Collaboration to Develop CRISPR-Based Therapies for the Treatment of Neurological and Muscular Diseases

REGN and NTLA Related Press Releases

Oct 3, 2023 07:00AM Regeneron and Intellia Announce Expanded Research Collaboration to Develop CRISPR-Based Therapies for the Treatment of Neurological and Muscular Diseases

REGN and NTLA Related SEC Filings